Evidence map›Paper›PMID 33897636›Full record

ArticleFrontiers in microbiology2021

Anti-biofilm Potential of

Abdullah, Ali Asghar, Ammar Algburi, Qingrong Huang, Talha Ahmad, Hao Zhong, Hafiz U Javed, Alexey M Ermakov, Michael L Chikindas

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. In Vitro and In Silico Screening of Anti-Plants (Basel, Switzerland) · 2022
    Article
  9. Novel Antibiofilm Inhibitor Ginkgetin as an Antibacterial Synergist againstInternational journal of molecular sciences · 2022
    Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

AbdullahCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Ali AsgharNational Institute of Food Science and Technology, University of Agriculture Faisalabad, Faisalabad, Pakistan.
Ammar AlgburiDepartment of Food Science, Rutgers State University, New Brunswick, NJ, United States.
Qingrong HuangDepartment of Food Science, Rutgers State University, New Brunswick, NJ, United States.
Talha AhmadCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Hao ZhongCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Hafiz U JavedDepartment of Plant Sciences, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, China.
Alexey M ErmakovCenter for Agrobiotechnology, Don State Technical University, Rostov-on-Don, Russia.
Michael L ChikindasCenter for Agrobiotechnology, Don State Technical University, Rostov-on-Don, Russia.
Rutgers, The State University of New Jersey · USUniversity of Faisalabad · PKZhejiang University · CNDon State Technical University · RUShanghai Jiao Tong University · CNUniversity of Diyala · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Foodborne pathogens, microbial recurrent infections, and antibiotic resistance have driven researchers to explore natural compounds as safe alternative antimicrobials. In this study, the chemical profile, antimicrobial, and mutagenic activities of the

Indexed as

anti-biofilm potentialbioactive compoundsEscherichia coli O157:H7GC-MS characterizationgreen cardamommutagenic activitySalmonella Typhimurium JSG 1748

Identifiers

PMID33897636
PMCPMC8062866
OpenAlexW3154067398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.